| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 14 | / | 2019 | ||||||||
| Date of issue: | 2019-06-03 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification concerning the Annual General meeting of shareholders – 07.06.2019 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD notifies that for the convenience of all shareholders the registration for participation in the Annual General meeting convened for 7 June 2019 will end at 10:45 am in order to allow for timely start of the General meeting. Please note that for the first year the General meeting will be held at the new Event Center, which is located on the Ground floor of Sopharma Business Towers. For registration and participation in the AGM, physical persons - shareholders must present an identity document. Legal entities - shareholders must provide an original or a certified copy of a valid commercial/court registration certificate as well as the legal representative's identity document. For securing the registration procedure for participation in the General meeting of shareholders, copies of the issued powers of attorney should be submitted to the Company in hard copy or in electronic form at the latest by the end of the business day preceding the date of the General meeting, namely 17.00 hours on 6 June 2019. Sopharma AD will receive and accept valid electronic notices and proxies by e-mail to the following e-mail address: [email protected] according to the instructions described in the Invitation for convening the Annual General meeting of shareholders. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_2019_AGM_registration_espi.pdf | Notification concerning the Annual General meeting of shareholders – 07.06.2019 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2019-06-03 | Ognian Donev | Executive director | |||
3JR_2019_AGM_registration_espi.pdf
